Display options
Cite
Naqvi A, Pandey A, Gupta V, et al. Assay method for quality control and stability studies of a new anti-diabetic and anti-dyslipidemic flavone (S002-853). Pharmacogn Mag. 2015;11:S53-9doi: 10.4103/0973-1296.157689.
Naqvi, A., Pandey, A., Gupta, V., Malasoni, R., Srivastava, A., Pandey, R. R., Satyanarayana, M., Pratap, R., & Dwivedi, A. K. (2015). Assay method for quality control and stability studies of a new anti-diabetic and anti-dyslipidemic flavone (S002-853). Pharmacognosy magazine, 11S53-9. https://doi.org/10.4103/0973-1296.157689
Naqvi, Arshi, et al. "Assay method for quality control and stability studies of a new anti-diabetic and anti-dyslipidemic flavone (S002-853)." Pharmacognosy magazine vol. 11 (2015): S53-9. doi: https://doi.org/10.4103/0973-1296.157689
Naqvi A, Pandey A, Gupta V, Malasoni R, Srivastava A, Pandey RR, Satyanarayana M, Pratap R, Dwivedi AK. Assay method for quality control and stability studies of a new anti-diabetic and anti-dyslipidemic flavone (S002-853). Pharmacogn Mag. 2015 May;11:S53-9. doi: 10.4103/0973-1296.157689. PMID: 26109774; PMCID: PMC4461968.
Copy Download .nbib Format: NLM
Share it on

Pharmacogn Mag. 2015 May;11:S53-9. doi: 10.4103/0973-1296.157689.

Assay method for quality control and stability studies of a new anti-diabetic and anti-dyslipidemic flavone (S002-853).

Pharmacognosy magazine

Arshi Naqvi, Anuja Pandey, Varsha Gupta, Richa Malasoni, Akansha Srivastava, Rishi Ranjan Pandey, M Satyanarayana, Ram Pratap, Anil Kumar Dwivedi

Affiliations

  1. Division of Pharmaceutics, Central Drug Research Institute, Lucknow, Uttar Pradesh, India.
  2. Medicinal and Process Chemistry Division, Central Drug Research Institute, Lucknow, Uttar Pradesh, India.

PMID: 26109774 PMCID: PMC4461968 DOI: 10.4103/0973-1296.157689

Abstract

BACKGROUND: Flavonoid-rich extract of the plant is long known for its anti-diabetic activities in traditional medicine. S002-853, a new flavone derivative synthesized by Central Drug Research Institute (CDRI) has been used for the present study.

OBJECTIVES: The present study aimed at development of an assay method for quality control (QC) and stability studies of a new anti-diabetic and anti-dyslipidemic agent CDRI compound S002-853.

MATERIALS AND METHODS: A validated high-performance liquid chromatography analysis method for S002-853 was developed for in process QC and stability studies. The separation was achieved on a RP-C18 (25 cm × 0.4 cm, 5 μm, Phenomenex) at 240 nm with flow rate of 1.0 ml/min. This method was applied successfully in establishing forced degradation and drug-excipient testing protocols as per International Conference on Harmonization guidelines.

RESULTS: The result of estimation and stress testing studies indicated a high degree of selectivity of this method. S002-853 was most stable at pH 7 and under photolytic conditions. The temperature degradation pattern of S002-853 was found to follow the zero order degradation.

CONCLUSION: The method described is easy and simple hence can be easily reproduced. This method can be very useful for bulk manufacture QC, and drug development process.

Keywords: Anti-diabetic; anti-dyslipidemic; flavone derivative; high performance liquid chromatography; in process quality control

References

  1. J Med Chem. 2012 May 24;55(10):4551-67 - PubMed
  2. Am J Cardiol. 2010 Mar 1;105(5):667-71 - PubMed
  3. Free Radic Biol Med. 1997;23(2):302-13 - PubMed
  4. Meta Gene. 2014 May 04;2:332-41 - PubMed
  5. Ann Intern Med. 1996 Jan 1;124(1 Pt 2):97-103 - PubMed
  6. Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Nov;26(11):882-7 - PubMed
  7. Bioorg Med Chem Lett. 2007 Feb 1;17(3):799-802 - PubMed
  8. Thromb Res. 2014 May;133(5):880-5 - PubMed
  9. Diabetes Care. 2004 May;27(5):1047-53 - PubMed
  10. BMJ. 2007 Feb 10;334(7588):299 - PubMed
  11. Arch Pharm Res. 2010 Mar;33(3):353-62 - PubMed
  12. Diabetologia. 1998 Oct;41(10):1241-8 - PubMed
  13. Free Radic Biol Med. 1992 Sep;13(3):211-9 - PubMed
  14. BMJ. 1998 Apr 18;316(7139):1221-5 - PubMed
  15. Acta Pol Pharm. 2011 May-Jun;68(3):423-33 - PubMed

Publication Types